Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

Carregando...
Imagem de Miniatura
Citações na Scopus
80
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMC
Autores
BOUSQUET, J. Jean
SCHUNEMANN, Holger J.
TOGIAS, Alkis
ERHOLA, Marina
HELLINGS, Peter W.
ZUBERBIER, Torsten
AGACHE, Ioana
ANSOTEGUI, Ignacio J.
ANTO, Josep M.
BACHERT, Claus
Citação
CLINICAL AND TRANSLATIONAL ALLERGY, v.9, n.1, article ID 44, 15p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health care effectively. There is a need to support the transformation of the health care system into integrated care with organizational health literacy. Main body As an example for chronic disease care, MASK (Mobile Airways Sentinel NetworK), a new project of the ARIA (Allergic Rhinitis and its Impact on Asthma) initiative, and POLLAR (Impact of Air POLLution on Asthma and Rhinitis, EIT Health), in collaboration with professional and patient organizations in the field of allergy and airway diseases, are proposing real-life ICPs centred around the patient with rhinitis, and using mHealth to monitor environmental exposure. Three aspects of care pathways are being developed: (i) Patient participation, health literacy and self-care through technology-assisted ""patient activation"", (ii) Implementation of care pathways by pharmacists and (iii) Next-generation guidelines assessing the recommendations of GRADE guidelines in rhinitis and asthma using real-world evidence (RWE) obtained through mobile technology. The EU and global political agendas are of great importance in supporting the digital transformation of health and care, and MASK has been recognized by DG Sante as a Good Practice in the field of digitally-enabled, integrated, person-centred care. Conclusion In 20 years, ARIA has considerably evolved from the first multimorbidity guideline in respiratory diseases to the digital transformation of health and care with a strong political involvement.
Palavras-chave
Health care transformation, Care pathways, Rhinitis, ARIA, MASK, POLLAR
Referências
  1. Adams K, 2004, 1 ANN CROSSING QUALI
  2. Alonso-Coello P, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2016
  3. Amaral R, 2018, CLIN TRANSL ALLERGY, V8, DOI 10.1186/s13601-018-0201-3
  4. [Anonymous], 2017, MED LETT DRUGS THER, V59, pe70
  5. Bachert C, 2018, CLIN TRANSL ALLERGY, V8, DOI 10.1186/s13601-018-0210-2
  6. Bastl K, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7426
  7. Bateman ED, 2018, NEW ENGL J MED, V378, P1877, DOI 10.1056/NEJMoa1715275
  8. Bedard A, 2019, J ALLERGY CLIN IMMUN, V144, P135, DOI 10.1016/j.jaci.2019.01.053
  9. Bhattarai P, 2017, ARCH GERONTOL GERIAT, V68, P14, DOI 10.1016/j.archger.2016.08.008
  10. Bianchi A, 2016, J INVEST ALLERG CLIN, V26, P204, DOI 10.18176/jiaci.0060
  11. Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469
  12. Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x
  13. Bousquet J, 2007, ALLERGY, V62, P216, DOI 10.1111/j.1398-9995.2007.01307.x
  14. Bousquet J, 2006, J ALLERGY CLIN IMMUN, V117, P158, DOI 10.1016/j.jaci.2005.09.047
  15. Bousquet J, 2005, CLIN EXP ALLERGY, V35, P728, DOI 10.1111/j.1365-2222.2005.02274.x
  16. Bousquet J, 2018, CLIN TRANSL ALLERGY, V8, DOI 10.1186/s13601-018-0227-6
  17. Bousquet J, 2018, ALLERGY, V73, P1763, DOI 10.1111/all.13406
  18. Bousquet J, 2016, CLIN TRANSL ALLERGY, V6, DOI 10.1186/s13601-016-0137-4
  19. Bousquet J, 2015, THORAX, V70, P595, DOI 10.1136/thoraxjnl-2014-206304
  20. Bousquet J, 2014, EUR GERIATR MED, V5, P361, DOI 10.1016/j.eurger.2014.09.010
  21. Bousquet J, 2014, EUR RESPIR J, V44, P304, DOI 10.1183/09031936.00014614
  22. Bousquet J, 2004, ALLERGY, V59, P373
  23. Bousquet J, 2013, ALLERGY, V68, P555, DOI 10.1111/all.12115
  24. Bousquet J, 2003, ALLERGY, V58, P733, DOI 10.1034/j.1398-9995.2003.00076.x
  25. Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891
  26. Bousquet J, 2019, J ALLERGY CLIN IMMUN
  27. Bousquet J, 2018, J ALLERGY CLIN IMMUN
  28. Bousquet J, 2019, J ALLERGY CLIN IMMUN, V143, P864, DOI 10.1016/j.jaci.2018.08.049
  29. Bousquet J, 2018, CLIN TRANSL ALLERGY, V8, DOI 10.1186/s13601-018-0221-z
  30. Bousquet J, 2018, ANN ALLERG ASTHMA IM, V121, P741, DOI 10.1016/j.anai.2018.07.034
  31. Bousquet J, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00447-2017
  32. Bousquet J, 2016, EUR RESPIR J, V47, P1028, DOI 10.1183/13993003.01856-2015
  33. Bousquet J, 2011, GENOME MED, V3, DOI 10.1186/gm259
  34. Bousquet J, 2009, INT ARCH ALLERGY IMM, V150, P75, DOI 10.1159/000210383
  35. Bousquet PJ, 2015, INT ARCH ALLERGY IMM, V166, P231, DOI 10.1159/000381339
  36. Brozek JL, 2008, ALLERGY, V63, P38, DOI 10.1111/j.1398-9995.2007.01560.x
  37. Brozek JL, 2009, ALLERGY, V64, P669, DOI 10.1111/j.1398-9995.2009.01973.x
  38. Brozek JL, 2017, J ALLERGY CLIN IMMUN, V140, P950, DOI 10.1016/j.jaci.2017.03.050
  39. Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047
  40. Camargos P, 2018, CLIN TRANSL ALLERGY, V8, DOI 10.1186/s13601-018-0192-0
  41. Campbell H, 1998, BMJ-BRIT MED J, V316, P133
  42. Canonica G Walter, 2015, Clin Mol Allergy, V13, P25, DOI 10.1186/s12948-015-0029-5
  43. Carney AS, 2017, PRAGMAT OBS RES, V8, P157, DOI 10.2147/POR.S134266
  44. Carr WW, 2017, POSTGRAD MED, V129, P572, DOI 10.1080/00325481.2017.1333384
  45. Chisholm-Burns MA, 2010, MED CARE, V48, P923, DOI 10.1097/MLR.0b013e3181e57962
  46. Cingi C, 2017, CLIN TRANSL ALLERGY, V7, DOI 10.1186/s13601-017-0153-z
  47. Costa C, 2014, EUR ANN ALLERGY CLIN, V46, P216
  48. Costa DJ, 2011, J ALLERGY CLIN IMMUN, V127, P920, DOI 10.1016/j.jaci.2010.10.058
  49. Crespi-Lofton J, 2017, J AM PHARM ASSOC, V57, pE15, DOI 10.1016/j.japh.2017.05.014
  50. De Greve G, 2017, CLIN TRANSL ALLERGY, V7, DOI 10.1186/s13601-017-0157-8
  51. del Cuvillo A, 2010, RHINOLOGY, V48, P201, DOI 10.4193/Rhin09.099
  52. Dieleman JL, 2017, LANCET, V389, P2005, DOI 10.1016/S0140-6736(17)30873-5
  53. Dykewicz MS, 2017, ANN ALLERG ASTHMA IM, V119, P489, DOI 10.1016/j.anai.2017.08.012
  54. Farmanova E, 2018, INQUIRY-J HEALTH CAR, V55, DOI 10.1177/0046958018757848
  55. Flandroy L, 2018, SCI TOTAL ENVIRON, V627, P1018, DOI 10.1016/j.scitotenv.2018.01.288
  56. Fromer LM, 2014, ALLERGY ASTHMA PROC, V35, P307, DOI 10.2500/aap.2014.35.3766
  57. Gray WN, 2018, PEDIATR PULM, V53, P668, DOI 10.1002/ppul.23966
  58. Hellings PW, 2017, CLIN TRANSL ALLERGY, V7, DOI 10.1186/s13601-017-0186-3
  59. Hibbard J, 2014, SUPPORTING PEOPLE MA
  60. Huang X, 2016, CLIN REV ALLERGY IMM
  61. Hui CY, 2017, J AM MED INFORM ASSN, V24, P619, DOI 10.1093/jamia/ocw143
  62. Hujala A, 2017, SUPPORT INTEGRATION
  63. Hunter DJ, 2015, J HEALTH ORGAN MANAG, V29, P10, DOI 10.1108/JHOM-01-2014-0019
  64. Jauregui I, 2011, PEDIAT ALLERG IMM-UK, V22, P388, DOI 10.1111/j.1399-3038.2010.01108.x
  65. Kuipers E, 2017, INT J CLIN PHARM-NET, V39, P888, DOI 10.1007/s11096-017-0495-6
  66. Lee JK, 2013, J AM GERIATR SOC, V61, P1119, DOI 10.1111/jgs.12323
  67. Levine DM, 2015, J GEN INTERN MED, V30, P107, DOI 10.1007/s11606-014-2987-6
  68. Lombardi C, 2015, ASTHMA RES PRACT, V1, P1
  69. Lourenco O, 2014, J MANAG CARE SPEC PH, V20, P513, DOI 10.18553/jmcp.2014.20.5.513
  70. Mosen DM, 2007, J AMBUL CARE MANAG, V30, P21
  71. Muraro A, 2016, ALLERGY, V71, P583, DOI 10.1111/all.12819
  72. Neumann I, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0462-y
  73. O'Byrne PM, 2018, NEW ENGL J MED, V378, P1865, DOI 10.1056/NEJMoa1715274
  74. O'Connor J, 2008, PATIENT EDUC COUNS, V70, P111, DOI 10.1016/j.pec.2007.09.004
  75. Overill S, 1998, J INTEGR CARE, V2, P93
  76. Padjas A, 2014, J ALLERGY CLIN IMMUN, V133, P777, DOI 10.1016/j.jaci.2013.08.029
  77. Palmer K, 2018, HEALTH POLICY, V122, P4, DOI 10.1016/j.healthpol.2017.09.006
  78. Parmelli E, 2017, INT J TECHNOL ASSESS, V33, P176, DOI 10.1017/S0266462317000447
  79. Pearce G, 2016, J HEALTH SERV RES PO, V21, P73, DOI 10.1177/1355819615602725
  80. Pinnock H, 2017, SELF MANAGEMENT RESP
  81. Pinnock H, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0361-0
  82. Pizzulli A, 2014, CLIN EXP ALLERGY, V44, P1246, DOI 10.1111/cea.12386
  83. Porteous T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-217
  84. Rachelefsky G, 2014, J ALLER CL IMM-PRACT, V2, P271, DOI 10.1016/j.jaip.2014.01.006
  85. Richard AA, 2011, J NURS SCHOLARSHIP, V43, P255, DOI 10.1111/j.1547-5069.2011.01404.x
  86. Russell J, 2012, SOC SCI MED, V75, P2463, DOI 10.1016/j.socscimed.2012.09.026
  87. Samolinski B, 2012, LANCET, V379, pE45, DOI 10.1016/S0140-6736(12)60514-5
  88. Samreth D, 2018, WORLD ALLERGY ORGAN, V11, DOI 10.1186/s40413-018-0194-3
  89. Schunemann HJ, 2007, PLOS MED, V4, P786, DOI 10.1371/journal.pmed.0040119
  90. Schunemann HJ, 2016, J CLIN EPIDEMIOL, V76, P89, DOI 10.1016/j.jclinepi.2016.01.032
  91. Seys SF, 2018, RHINOLOGY, V56, P209, DOI 10.4193/Rhin17.253
  92. Silva DD, 2011, HELPING PEOPLE HELP
  93. Singh D, REV UK INT FRAMEWORK
  94. Skypala IJ, 2018, CLIN TRANSL ALLERGY, V8, DOI 10.1186/s13601-018-0218-7
  95. Smith L, 2014, HEALTH EXPECT, V17, P154, DOI 10.1111/j.1369-7625.2011.00746.x
  96. Smith L, 2011, PATIENT EDUC COUNS, V85, pE26, DOI 10.1016/j.pec.2010.10.003
  97. Smith P, 2017, J ASTHMA ALLERGY, V10, P153, DOI 10.2147/JAA.S128431
  98. Stenberg K, 2018, COST EFFECT RESOUR A, V16, DOI 10.1186/s12962-018-0095-x
  99. Sullivan PW, 2005, AM J MANAG CARE, V11, P374
  100. Valiulis A, 2019, CLIN TRANSL ALLERGY, V9, DOI 10.1186/s13601-019-0242-2
  101. van der Gronde T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182613
  102. Van der Roest HG, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009627.pub2
  103. Vandenplas O, 2018, J ALLER CL IMM-PRACT, V6, P1274, DOI 10.1016/j.jaip.2017.09.002
  104. Walls RS, 2005, MED J AUSTRALIA, V182, P28, DOI 10.5694/j.1326-5377.2005.tb06551.x